ImmunoPrecise Antibodies Ltd (IPA)
1.13
-0.04
(-3.42%)
USD |
NASDAQ |
May 23, 12:25
ImmunoPrecise Antibodies Total Liabilities (Quarterly): 21.54M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 21.54M |
| October 31, 2023 | 17.05M |
| July 31, 2023 | 17.15M |
| April 30, 2023 | 14.65M |
| January 31, 2023 | 15.96M |
| October 31, 2022 | 15.44M |
| July 31, 2022 | 10.57M |
| April 30, 2022 | 14.19M |
| January 31, 2022 | 6.865M |
| October 31, 2021 | 7.608M |
| July 31, 2021 | 7.212M |
| April 30, 2021 | 8.174M |
| January 31, 2021 | 8.872M |
| October 31, 2020 | 9.476M |
| July 31, 2020 | 10.07M |
| April 30, 2020 | 8.699M |
| January 31, 2020 | 8.408M |
| October 31, 2019 | 8.936M |
| July 31, 2019 | 9.251M |
| April 30, 2019 | 7.724M |
| January 31, 2019 | 6.910M |
| October 31, 2018 | 7.93M |
| July 31, 2018 | 8.931M |
| April 30, 2018 | 9.243M |
| January 31, 2018 | 2.381M |
| Date | Value |
|---|---|
| October 31, 2017 | 2.073M |
| July 31, 2017 | 0.4338M |
| April 30, 2017 | 0.6139M |
| January 31, 2017 | 0.5666M |
| September 30, 2016 | 0.1836M |
| June 30, 2016 | 0.1864M |
| March 31, 2016 | 0.1999M |
| December 31, 2015 | 0.1843M |
| September 30, 2015 | 0.1785M |
| June 30, 2015 | 0.1929M |
| March 31, 2015 | 0.205M |
| December 31, 2014 | 0.2194M |
| September 30, 2014 | 0.2412M |
| June 30, 2014 | 0.2703M |
| March 31, 2014 | 0.26M |
| December 31, 2013 | 0.285M |
| September 30, 2013 | 0.2779M |
| June 30, 2013 | 0.2748M |
| March 31, 2013 | 0.2653M |
| December 31, 2012 | 0.267M |
| September 30, 2012 | 0.2413M |
| June 30, 2012 | 0.2207M |
| March 31, 2012 | 0.2331M |
| December 31, 2011 | 0.2087M |
| September 30, 2011 | 0.1776M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.865M
Minimum
Jan 2022
21.54M
Maximum
Jan 2024
11.58M
Average
9.476M
Median
Oct 2020
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.71M |
| Shareholders Equity (Quarterly) | 37.17M |
| Current Ratio | 1.657 |